70 likes | 77 Views
Nifty extended their gains even as investors remained wary of the economic growth forecast weighed against higher oil prices while the building-up of trade tensions continued. Nifty closed above its resistance i.e. of 10710 which indicates buying in Index.
E N D
; Daily Equity Report 04-7-2018 support@starindiaresearch.com8817002233 Outlook of Nifty & Bank Nifty Today Nifty Outlook:- Nifty Future Support- Resistance Nifty extended their gains even as investors remained wary of the economic growth forecast weighed against higher oil prices while the building- up of trade tensions continued. Nifty closed above its resistance i.e. of 10710 which indicates buying in Index. R1/R2 10820/10880 S1/S2 10630/10530 Daily Chart:
; Daily Newsletter Page 2 Bank Nifty Outlook:- Bank Nifty Future Support- Resistance Bank Nifty recouped some previous day's losses to close in the green after volatility. Ongoing trade tensions between world's largest economies US and China capped gains. Bank Nifty closed on flat to positive note buying activity could be seen if manage to give breakouts of its 20 DMA which can be seen in below daily charts. R1/R2 26500/26850 S1/S2 26000/25550 Daily Chart: Technical Outlook Top Losers VEDL INFRATEL ICICIBANK HDFC Top Gainers CIPLA BAJAJFINSV MARUTI LUPIN 231 291.5 273.25 1,882.05 643 5,897.55 8,988.75 906.1
; Daily Newsletter Page 3 Stock Corner: Maruti Suzuki share price rallied 1.9 percent after global brokerage house JPMorgan has maintained overweight call on the stock with a target price at Rs 10,200 per share. Aban Offshore bags order from ONGC, The company informed exchanges that its step- down subsidiary Aban Singapore Pte Ltd has received a letter of award from Oil and Natural Gas Corporation. The order is for deployment of jack-up rig deep driller 8 for a firm period of 2 years. Shares of Ashoka Buildcon gained as much as 2.6 percent in the afternoon trade after receiving arbitration award related to Rajasthan project. 1. 2. Aurobindo Pharma has received USFDA approval for Ibuprofen OTC capsules. It is a painkiller drug. Shree Renuka Sugars' director resigns: Sanjay Asher, non-executive independent director has resigned from the directorship of company with effect from end of day on July 2, 2018. Syndicate Bank clarified that credit facility given to DS Kulkarni was in compliance with RBI guidelines. ITC and Ballarpur Industries clarify that no negotiations have taken place for ITC acquiring BILT’s Telengana unit. 3. 4. 5. 6. 7. Stock in ban period NIL.
Daily Newsletter ; Page 4 Technical outlook of top 2 stocks AJANTPHARM FUT Pharma stocks saw buying in today’s trading session as well as stock end with big bullish candle buying seen from current levels. INTRADAY 1080 1130 1185 1040 965 895 R1 R2 R3 Stock Info VOLUME DAY HIGH DAY LOW 1414000 1040 978 LEVEL S1 S2 MARKET LOT SIZE 500 S3 890 VWAP 1017.92 All over trend Sideways to Positive
Daily Newsletter ; Page 5 RBLBANK FUT Stock gains and closed its all time high which can be seen above daily charts, rally can be seen in coming session. INTRADAY R1 R2 R3 575 580 590 573 550 530 515 Stock Info VOLUME DAY HIGH DAY LOW MARKET LOT SIZE VWAP 3327600 571.35 552.10 1200 563.97 LEVEL S1 S2 S3 All over trends BULLISH
Daily Newsletter ; Page 6 Event Calendar (02nd June to 07th June) 02/07/18 (Mon) 03/07/18 (tues) 04/07/18 (wed) 05/07/18 (thurs) 06/07/18 (Fri) 07/07/18 (sat) - - - - - - Daily Calls INTRADAY BASIC CALLS DATE 03/07/18 03/07/18 03/07/18 Service Cash Future Option Stock Name RITES CEATLTD FUT TATAELXSI 1340 CE Entry Price 217.50 1253 42.50 Exit 222 1265 46.90 Profit/loss 6150 4200 5040 HNI CALLS DATE 03/07/18 03/07/18 03/07/18 Service Cash Future Option Stock Name GODREJCP WOCKPHARMA FUT RBLBANK 560 CE Entry Price 1240 566 18 Exit 1255 570.50 21 Profit/loss 12097 24750 18000 Report by Senior Researcher : Miss Namrata Otwani
Daily Newsletter ; Page 7 DISCLAIMER Entering our site means that you have read, understood and agreed to everything that is written and implied in this disclaimer note. RESEARCH is published solely for informational purposes and must in no way be construed as investme7nt advice for a specific individual. The information and views in this website & all the services we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Investment in equity shares, futures, options and commodities has its own risks. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and on sources that we consider reliable. We, however, do not vouch for the accuracy or the completeness thereof. This material is for personal information and we are not responsible for any loss incurred due to it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above. The information contained herein is from sources believed reliable. We do not represent that it is accurate, complete and it should not be relied upon as such. Any action taken by you on the basis of the information contained in this site is your responsibility only and we will not be liable in any manner for the consequences of such action taken by you. Our Clients (Paid or Unpaid), any third party or anyone else have no rights to forward or share our calls or SMS or Reports or any other information provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken. By accessing our site or any of its associate/group sites, you have read, understood and agree to be legally bound by the terms of the following disclaimer and user agreement Star India Market Research and its owners/affiliates are not liable for damages caused by any performance, failure of performance, error, omission, interruption, deletion, defect, delay in transmission or operations, computer virus, communications line failure, and unauthorized access to the personal accounts. Research House is not responsible for any technical failure or malfunction of the software or delays of any kind. We are also not responsible for non- receipt of registration details or e-mails. You understand and agree that no joint venture, partnership, employment or agency relationship exists between you and Research House as a result of this agreement or on account of use of our website. Price and availability of products and services offered on the site are subject to change without prior notice. We provide information about the availability of products or services to a certain extent but you should not rely on such information. Star India will not be liable for any lack of availability of products and services you may order through the site. www.starindiaresearch.com